{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:50:59Z","timestamp":1761763859605},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1038\/sj.pcan.4500610","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T18:31:41Z","timestamp":1047580301000},"page":"316-325","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters"],"prefix":"10.1038","volume":"5","author":[{"given":"S","family":"Ebara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T L","family":"Timme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Aguilar-Cordova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T C","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,12,18]]},"reference":[{"key":"BF4500610_CR1","first-page":"1","volume":"11","author":"TC Thompson","year":"1999","unstructured":"Thompson TC . In situ gene therapy for prostate cancer Oncol Res 1999 11: 1\u20138","journal-title":"Oncol Res"},{"key":"BF4500610_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0090-4295(00)00903-1","volume":"57","author":"M Shalev","year":"2001","unstructured":"Shalev M et al. Gene therapy for prostate cancer Urology 2001 57: 8\u201316","journal-title":"Urology"},{"key":"BF4500610_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/hum.1996.7.4-515","volume":"7","author":"JA Eastham","year":"1996","unstructured":"Eastham JA et al. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models Hum Gene Ther 1996 7: 515\u2013523","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<183::AID-IJC8>3.0.CO;2-T","volume":"70","author":"SJ Hall","year":"1997","unstructured":"Hall SJ et al. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer Int J Cancer 1997 70: 183\u2013187","journal-title":"Int J Cancer"},{"key":"BF4500610_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.cgt.7700004","volume":"6","author":"SJ Hall","year":"1999","unstructured":"Hall SJ et al. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer Cancer Gene Ther 1999 6: 54\u201363","journal-title":"Cancer Gene Ther"},{"key":"BF4500610_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1089\/10430349950018229","volume":"10","author":"JR Herman","year":"1999","unstructured":"Herman JR et al. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial Hum Gene Ther 1999 10: 1239\u20131249","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR7","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0022-5347(05)67534-9","volume":"163","author":"M Shalev","year":"2000","unstructured":"Shalev M et al. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer J Urol 2000 163: 1747\u20131750","journal-title":"J Urol"},{"key":"BF4500610_CR8","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1089\/104303401753204535","volume":"12","author":"BJ Miles","year":"2001","unstructured":"Miles BJ et al. Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy Hum Gene Ther 2001 12: 1955\u20131967","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1053\/hupa.2000.8453","volume":"31","author":"G Ayala","year":"2000","unstructured":"Ayala G et al. Cytopathic effects of in situ gene therapy in prostate cancer Hum Pathol 2000 31: 866\u2013870","journal-title":"Hum Pathol"},{"key":"BF4500610_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0360-3016(01)01692-3","volume":"51","author":"BS Teh","year":"2001","unstructured":"Teh BS et al. Phase I\/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer\u2014a preliminary report Int J Radiat Oncol Biol Phys 2001 51: 605\u2013613","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF4500610_CR11","first-page":"2585","volume":"9","author":"D Klatzmann","year":"1998","unstructured":"Klatzmann D et al. A phase I\/II dose-escalation study of herpes simples virus type 1 thymidine kinase \u201csuicide\u201d gene therapy for metastatic melanoma. Study Group on Gene Therapy of Metastatic Melanoma Hum Gene Ther 1998 9: 2585\u20132594","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR12","first-page":"2595","volume":"9","author":"D Klatzmann","year":"1998","unstructured":"Klatzmann D et al. A phase I\/II study of herpes simplex virus type 1 thymidine kinase \u201csuicide\u201d gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma Hum Gene Ther 1998 9: 2595\u20132604","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR13","first-page":"2559","volume":"57","author":"R Rodriguez","year":"1997","unstructured":"Rodriguez R et al. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells Cancer Res 1997 57: 2559\u20132563","journal-title":"Cancer Res"},{"key":"BF4500610_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1089\/hum.1998.9.9-1323","volume":"9","author":"SO Freytag","year":"1998","unstructured":"Freytag SO et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy Hum Gene Ther 1998 9: 1323\u20131333","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0065-3527(00)55014-3","volume":"55","author":"MM Hitt","year":"2000","unstructured":"Hitt MM, Graham FL . Adenovirus vectors for human gene therapy Adv Virus Res 2000 55: 479\u2013505","journal-title":"Adv Virus Res"},{"key":"BF4500610_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1040-8428(01)00103-2","volume":"38","author":"E Galanis","year":"2001","unstructured":"Galanis E, Vile R, Russell SJ . Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors Crit Rev Oncol Hematol 2001 38: 177\u2013292","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF4500610_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/10430349950018364","volume":"10","author":"DA Muruve","year":"1999","unstructured":"Muruve DA, Barnes MJ, Stillman IE, Libermann TA . Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo Hum Gene Ther 1999 10: 965\u2013976","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.gt.3300637","volume":"5","author":"MM van der Eb","year":"1998","unstructured":"van der Eb MM et al. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration Gene Ther 1998 5: 451\u2013458","journal-title":"Gene Ther"},{"key":"BF4500610_CR19","first-page":"5283","volume":"55","author":"S Kaneko","year":"1995","unstructured":"Kaneko S et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression Cancer Res 1995 55: 5283\u20135287","journal-title":"Cancer Res"},{"key":"BF4500610_CR20","first-page":"191","volume":"2","author":"KN Wills","year":"1995","unstructured":"Wills KN et al. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene Cancer Gene Ther 1995 2: 191\u2013197","journal-title":"Cancer Gene Ther"},{"key":"BF4500610_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/sj.gt.3300728","volume":"5","author":"K Brand","year":"1998","unstructured":"Brand K et al. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk\/GCV approach Gene Ther 1998 5: 1363\u20131371","journal-title":"Gene Ther"},{"key":"BF4500610_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0022-5347(01)63094-5","volume":"160","author":"A Gotoh","year":"1998","unstructured":"Gotoh A et al. Development of human prostate cancer J Urol 1998 160: 220\u2013229","journal-title":"J Urol"},{"key":"BF4500610_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s003450050181","volume":"18","author":"KS Koeneman","year":"2000","unstructured":"Koeneman KS et al. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis World J Urol 2000 18: 102\u2013110","journal-title":"World J Urol"},{"key":"BF4500610_CR24","first-page":"4272","volume":"7","author":"C Pramudji","year":"2001","unstructured":"Pramudji C et al. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter Clin Cancer Res 2001 7: 4272\u20134279","journal-title":"Clin Cancer Res"},{"key":"BF4500610_CR25","first-page":"1873","volume":"4","author":"G Yang","year":"1998","unstructured":"Yang G et al. Elevated expression of caveolin is associated with prostate and breast cancer Cliin Cancer Res 1998 4: 1873\u20131880","journal-title":"Cliin Cancer Res"},{"key":"BF4500610_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/2048","volume":"14","author":"Y Nasu","year":"1998","unstructured":"Nasu Y et al. Suppression of caveolin expression induces oxygen androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. [See comments.] Nat Med 1998 14: 1062\u20131064","journal-title":"Nat Med"},{"key":"BF4500610_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/0092-8674(89)90625-9","volume":"56","author":"TC Thompson","year":"1989","unstructured":"Thompson TC, Southgate J, Kitchener G, Land H . Multistage carcinogenesis induced by ras and myc oncogenes ina reconstituted organ Cell 1989 56: 917\u2013930","journal-title":"Cell"},{"key":"BF4500610_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0960-0760(95)00001-G","volume":"52","author":"PA Baley","year":"1995","unstructured":"Baley PA et al. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer J Steroid Biochem Mol Biol 1995 52: 403\u2013413","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF4500610_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli Y, Sherman Y, Ben-Sasson SA . Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 1992 119: 493\u2013501","journal-title":"J Cell Biol"},{"key":"BF4500610_CR30","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1073\/pnas.91.8.3054","volume":"91","author":"SH Chen","year":"1994","unstructured":"Chen SH et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo Proc Natl Acad Sci USA 1994 91: 3054\u20133057","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4500610_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/hum.1996.7.10-1241","volume":"7","author":"JC Goodman","year":"1996","unstructured":"Goodman JC et al. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies Hum Gene Ther 1996 7: 1241\u20131250","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR32","first-page":"74","volume":"5","author":"TL Timme","year":"1998","unstructured":"Timme TL et al. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice Cancer Gene Ther 1998 5: 74\u201382","journal-title":"Cancer Gene Ther"},{"key":"BF4500610_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.pcan.4500494","volume":"4","author":"Y Nasu","year":"2001","unstructured":"Nasu Y et al. Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer Prostate Cancer Prostat Dis 2001 4: 44\u201355","journal-title":"Prostate Cancer Prostat Dis"},{"key":"BF4500610_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/mthe.2000.0030","volume":"1","author":"TW Trask","year":"2000","unstructured":"Trask TW et al. Phase I study of adenoviral delivery of the HSF-tk gene and ganciclovir administration in patients with current malignant brain tumors Mol Ther 2000 1: 195\u2013203","journal-title":"Mol Ther"},{"key":"BF4500610_CR35","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/sj.onc.1203654","volume":"19","author":"TL Timme","year":"2000","unstructured":"Timme TL et al. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis Oncogene 2000 19: 3256\u20133265","journal-title":"Oncogene"},{"key":"BF4500610_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1172\/JCI115902","volume":"90","author":"LD Perricaudet","year":"1992","unstructured":"Perricaudet LD, Makeh I, Perricaudet M, Briand P . Widespread long-term gene transfer to mouse skeletal muscles and heart J Clin Invest 1992 90: 626\u2013630","journal-title":"J Clin Invest"},{"key":"BF4500610_CR37","first-page":"9","volume":"2","author":"J Wang","year":"1995","unstructured":"Wang J, Bucana C, Roth J, Zhang W . Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53 Cancer Gene Ther 1995 2: 9\u201317","journal-title":"Cancer Gene Ther"},{"key":"BF4500610_CR38","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm0797-808","volume":"3","author":"C Nyberg-Hoffman","year":"1997","unstructured":"Nyberg-Hoffman C et al. Sensitivity and reproducibility in adenoviral infectious titer determination Nat Med 1997 3: 808\u2013811","journal-title":"Nat Med"},{"key":"BF4500610_CR39","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","volume":"70","author":"N Mittereder","year":"1996","unstructured":"Mittereder N, March KL, Trapnell BC . Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J Virol 1996 70: 7498\u20137509","journal-title":"J Virol"},{"key":"BF4500610_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/sj.gt.3300834","volume":"6","author":"Y Nasu","year":"1999","unstructured":"Nasu Y et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model Gene Ther 1999 6: 338\u2013349","journal-title":"Gene Ther"},{"key":"BF4500610_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0168-9525(85)90088-5","volume":"1","author":"E Serfling","year":"1985","unstructured":"Serfling E, Jasin M, Schaffner W . Enhancers and eukaryotic gene transcription Trends Genet 1985 1: 224\u2013230","journal-title":"Trends Genet"},{"key":"BF4500610_CR42","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1099\/0022-1317-78-7-1653","volume":"78","author":"CL Addison","year":"1997","unstructured":"Addison CL, Hitt M, Kunsken D, Graham FL . Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors J Gen Virol 1997 78: 1653\u20131661","journal-title":"J Gen Virol"},{"key":"BF4500610_CR43","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/sj.gt.3300695","volume":"5","author":"MJ Driesse","year":"1998","unstructured":"Driesse MJ et al. Intracerebral injection of adenovirus harbouring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates Gene Ther 1998 5: 1122\u20131129","journal-title":"Gene Ther"},{"key":"BF4500610_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/10430340152712665","volume":"13","author":"JN Lozier","year":"2002","unstructured":"Lozier JN et al. Toxicity of a first-generation adenoviral vector in rhesus macaques Hum Gene Ther 2002 13: 113\u2013124","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/10430340152712692","volume":"13","author":"N Morral","year":"2002","unstructured":"Morral N et al. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons Hum Gene Ther 2002 13: 143\u2013154","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR46","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1128\/JVI.74.9.3941-3947.2000","volume":"74","author":"SL Borgland","year":"2000","unstructured":"Borgland SL et al. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsis-dependent activation of NF-kappaB J Virol 2000 74: 3941\u20133947","journal-title":"J Virol"},{"key":"BF4500610_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/10430340252792503","volume":"13","author":"GP Bowen","year":"2002","unstructured":"Bowen GP et al. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappaB Hum Gene Ther 2002 13: 367\u2013379","journal-title":"Hum Gene Ther"},{"key":"BF4500610_CR48","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1006\/mthe.2001.0329","volume":"3","author":"Y Zhang","year":"2001","unstructured":"Zhang Y et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages Mol Ther 2001 3: 697\u2013707","journal-title":"Mol Ther"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4500610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500610","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:22:17Z","timestamp":1648678937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4500610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12,1]]}},"alternative-id":["BF4500610"],"URL":"https:\/\/doi.org\/10.1038\/sj.pcan.4500610","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]},"assertion":[{"value":"4 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}